|Day Low/High||1.97 / 2.13|
|52 Wk Low/High||4.02 / 12.25|
The Technology is a Candidate to Treat Emerging Bioterror and Pandemic Threats
Results will add to Published Data Involving Candidate Biomarker to Identify & Monitor CTE
Biotech columnist Adam Feuerstein answers readers' questions about health care.
Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that James A.